Reuters/ Mike Segar
Regeneron Pharmaceuticals shares surged more than 7% Tuesday, gaining on its lead as the top performing stock in the S&P 500 this year.
The pharmaceutical company on Tuesday reported first quarter 2020 results that exceeded Wall Str…
Regeneron widens its lead as the S&P 500’s top performer after saying key COVID-19 drug may be available in the fall (REGN)
